Equities

Pacira Biosciences Inc

Pacira Biosciences Inc

Actions
  • Price (EUR)15.90
  • Today's Change-0.50 / -3.05%
  • Shares traded0.00
  • 1 Year change-40.23%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue675667542
OPERATING EXPENSES
Cost of revenue total185199140
Selling, general and admin. expenses, total269255199
Depreciation/amortization575714
Unusual expense(income)171143
Other operating expenses, total------
Total operating expense604607452
Operating income716090
Other, net(0.19)(11)(0.07)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes621356
Provision for income taxes20(2.61)14
Net income after taxes421642
Minority interest------
Net income before extra. Items421642
Total extraordinary items------
Net income421642
Inc.avail. to common excl. extra. Items421642
Inc.avail. to common incl. extra. Items421642
EPS RECONCILIATION
Basic/primary weighted average shares464644
Basic/primary eps excl. extra items0.910.350.95
Basic/primary eps incl. extra items0.910.350.95
Dilution adjustment4.11----
Diluted weighted average shares524746
Diluted eps excl. extra items0.890.340.92
Diluted eps incl. extra items0.890.340.92
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental204032
SUPPLEMENTAL INCOME
Depreciation, supplemental183415
Total special items171143
NORMALISED INCOME
Normalized income before taxes782499
Effect of special items on income taxes5.303.8211
Income tax excluding impact of special items251.2125
Normalized income after tax532374
Normalized income avail. to common532374
Basic normalized EPS1.150.511.67
Diluted normalized EPS1.100.491.62
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.